X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35715) 35715
Book Chapter (96) 96
Newsletter (68) 68
Magazine Article (31) 31
Dissertation (23) 23
Conference Proceeding (22) 22
Book / eBook (7) 7
Publication (6) 6
Newspaper Article (5) 5
Web Resource (4) 4
Book Review (3) 3
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30693) 30693
science & technology (22296) 22296
life sciences & biomedicine (21261) 21261
female (20404) 20404
cisplatin - administration & dosage (19610) 19610
antineoplastic combined chemotherapy protocols - therapeutic use (19162) 19162
male (17783) 17783
middle aged (16279) 16279
oncology (14542) 14542
aged (13517) 13517
adult (13045) 13045
cisplatin (11234) 11234
cisplatin - therapeutic use (9556) 9556
chemotherapy (8675) 8675
cancer (6870) 6870
combined modality therapy (6399) 6399
treatment outcome (6396) 6396
cisplatin - adverse effects (5799) 5799
animals (5286) 5286
antineoplastic combined chemotherapy protocols - adverse effects (5237) 5237
antineoplastic agents - therapeutic use (5165) 5165
lung neoplasms - drug therapy (4989) 4989
neoplasm staging (4928) 4928
fluorouracil - administration & dosage (4560) 4560
survival rate (4000) 4000
prognosis (3816) 3816
cisplatin - pharmacology (3453) 3453
drug administration schedule (3370) 3370
doxorubicin - administration & dosage (3339) 3339
etoposide - administration & dosage (3317) 3317
carcinoma, squamous cell - drug therapy (3183) 3183
mice (3082) 3082
cell line, tumor (3049) 3049
retrospective studies (3011) 3011
care and treatment (2989) 2989
carcinoma, non-small-cell lung - drug therapy (2983) 2983
ovarian neoplasms - drug therapy (2905) 2905
survival analysis (2889) 2889
aged, 80 and over (2784) 2784
disease-free survival (2769) 2769
apoptosis (2763) 2763
follow-up studies (2747) 2747
chemotherapy, adjuvant (2709) 2709
pharmacology & pharmacy (2657) 2657
antineoplastic agents - pharmacology (2368) 2368
lung neoplasms - pathology (2305) 2305
research (2281) 2281
adolescent (2273) 2273
deoxycytidine - analogs & derivatives (2247) 2247
adenocarcinoma - drug therapy (2230) 2230
abridged index medicus (2209) 2209
antineoplastic combined chemotherapy protocols - administration & dosage (2172) 2172
cyclophosphamide - administration & dosage (2148) 2148
antineoplastic agents - administration & dosage (2123) 2123
surgery (2058) 2058
tumors (2041) 2041
paclitaxel - administration & dosage (2029) 2029
vinblastine - administration & dosage (2022) 2022
analysis (2018) 2018
cancer therapies (1956) 1956
stomach neoplasms - drug therapy (1933) 1933
medicine & public health (1913) 1913
radiotherapy (1907) 1907
remission induction (1861) 1861
time factors (1842) 1842
dose-response relationship, drug (1823) 1823
deoxycytidine - administration & dosage (1817) 1817
health aspects (1801) 1801
prospective studies (1798) 1798
bleomycin - administration & dosage (1795) 1795
antineoplastic agents (1793) 1793
carboplatin - administration & dosage (1748) 1748
carcinoma, squamous cell - pathology (1718) 1718
antineoplastic agents - adverse effects (1711) 1711
apoptosis - drug effects (1703) 1703
ovarian cancer (1653) 1653
methotrexate - administration & dosage (1628) 1628
metastasis (1581) 1581
lung cancer (1557) 1557
antimitotic agents (1556) 1556
head and neck neoplasms - drug therapy (1530) 1530
lymphatic metastasis (1446) 1446
drug resistance (1441) 1441
drug resistance, neoplasm (1418) 1418
carcinoma, non-small-cell lung - pathology (1413) 1413
ovarian neoplasms - pathology (1400) 1400
neoadjuvant therapy (1377) 1377
radiotherapy dosage (1370) 1370
neoplasms - drug therapy (1364) 1364
hematology, oncology and palliative medicine (1362) 1362
stomach neoplasms - pathology (1351) 1351
drug therapy (1335) 1335
lung neoplasms - mortality (1321) 1321
proteins (1306) 1306
urinary bladder neoplasms - drug therapy (1300) 1300
research article (1269) 1269
neoplasm metastasis (1259) 1259
carcinoma, squamous cell - radiotherapy (1258) 1258
toxicity (1243) 1243
patients (1240) 1240
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32353) 32353
Japanese (3127) 3127
French (576) 576
Chinese (558) 558
German (431) 431
Russian (183) 183
Italian (147) 147
Spanish (142) 142
Polish (72) 72
Portuguese (37) 37
Hungarian (32) 32
Dutch (29) 29
Czech (18) 18
Bulgarian (17) 17
Ukrainian (13) 13
Korean (12) 12
Hebrew (11) 11
Romanian (9) 9
Danish (8) 8
Serbian (6) 6
Lithuanian (5) 5
Norwegian (4) 4
Finnish (3) 3
Slovak (3) 3
Croatian (2) 2
Arabic (1) 1
Bosnian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Book Review
Leukemia & Lymphoma, ISSN 1042-8194, 01/2015, Volume 56, Issue 1, pp. 57 - 64
Abstract We have studied the feasibility and efficacy of intensified R-MegaCHOP-ESHAP-BEAM therapy in high-risk aggressive B-cell lymphomas. Altogether 105... 
transplant | Lymphomas | B cells | chemotherapy | immunotherapy | Chemotherapy | Immunotherapy | Transplant | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Methylprednisolone - therapeutic use | Podophyllotoxin - adverse effects | Cytarabine - therapeutic use | Humans | Middle Aged | Podophyllotoxin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Methylprednisolone - adverse effects | Consolidation Chemotherapy | Cytarabine - adverse effects | Melphalan - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Carmustine - therapeutic use | Neoplasm Metastasis | Melphalan - adverse effects | Adult | Female | Carmustine - adverse effects | Lymphoma, B-Cell - drug therapy | Etoposide - adverse effects | Lymphoma, B-Cell - mortality | Prednisone - adverse effects | Etoposide - therapeutic use | Treatment Outcome | Disease Progression | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus
Journal Article
Biological & pharmaceutical bulletin, ISSN 0918-6158, 2016, Volume 39, Issue 4, pp. 611 - 614
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2014, Volume 15, Issue 9, pp. 1007 - 1018
Summary Background Dysregulation of the hepatocyte growth factor (HGF)/MET pathway promotes tumour growth and metastasis. Rilotumumab is a fully human,... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 10/2008, Volume 105, Issue 44, pp. 17079 - 17084
Journal Article
Journal of controlled release, ISSN 0168-3659, 10/2017, Volume 263, pp. 120 - 131
Systemically administered chemotherapeutic drugs are often ineffective in the treatment of invasive brain tumors due to poor therapeutic index... 
Focused ultrasound | Blood-brain barrier | Glioma | Nanoparticle | Cisplatin | Blood-tumor barrier | Brain - diagnostic imaging | Carbocyanines - chemistry | Carbocyanines - administration & dosage | Brain Neoplasms - diagnostic imaging | Magnetic Resonance Imaging - methods | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Fluorescent Dyes - therapeutic use | Polyethylene Glycols - therapeutic use | Brain Neoplasms - metabolism | Peptides - administration & dosage | Cisplatin - administration & dosage | Drug Delivery Systems | Glioma - metabolism | Brain - metabolism | Cisplatin - chemistry | Glioma - pathology | Microbubbles | Female | Fluorescent Dyes - administration & dosage | Ultrasonic Waves | Cell Survival - drug effects | Fluorescent Dyes - chemistry | Cadaverine - chemistry | Peptides - chemistry | Cadaverine - administration & dosage | Cadaverine - therapeutic use | Carbocyanines - therapeutic use | Antineoplastic Agents - chemistry | Brain Neoplasms - drug therapy | Rats, Sprague-Dawley | Polyethylene Glycols - administration & dosage | Animals | Glioma - diagnostic imaging | Cisplatin - therapeutic use | Tumor Burden - drug effects | Brain - pathology | Cell Line, Tumor | Drug Liberation | Glioma - drug therapy | Peptides - therapeutic use | Drugs | Drug delivery systems | Brain tumors | Antineoplastic agents | Polyols | Vehicles | Nanoparticles | Antimitotic agents | Chemotherapy | Magnetic resonance imaging | Gliomas | Analysis | Cancer | Medical colleges | Road construction | Polyethylene glycol | Biomedical engineering | Index Medicus | blood-brain barrier | glioma | nanoparticle | blood-tumor barrier | cisplatin | focused ultrasound
Journal Article